Francis J Duggan Jr., MD Urology Medicare: Not Enrolled in Medicare Practice Location: 423 N 21st St, Ste 300, Camp Hill, PA 17011 Phone: 717-763-1174 Fax: 717-763-8960 |
Robbyn Porter, CRNP Urology Medicare: Medicare Enrolled Practice Location: 100 Corporate Center Dr Ste 100, Camp Hill, PA 17011 Phone: 717-763-1174 Fax: 717-763-8960 |
Russell Scott Owens, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Corporate Center Dr Ste 100, Camp Hill, PA 17011 Phone: 717-763-1174 Fax: 717-763-8960 |
Thomas Kachel, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Corporate Center Dr, Suite 100, Camp Hill, PA 17011 Phone: 717-763-1174 Fax: 717-763-8960 |
Allen S Wenger, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 423 N 21st St, Suite 300, Camp Hill, PA 17011 Phone: 717-763-1174 Fax: 717-763-8960 |
Jaime Omar Herrera Caceres, MD, MSC Urology Medicare: Accepting Medicare Assignments Practice Location: 503 N 21st St, Camp Hill, PA 17011 Phone: 717-763-2100 |
Keith J Dowling, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 423 N 21st St, Ste 300, Camp Hill, PA 17011 Phone: 717-763-1174 Fax: 717-763-8960 |
Dr. Adrian Sosenko, Urology Medicare: Medicare Enrolled Practice Location: 429 N 21st St, Camp Hill, PA 17011 Phone: 717-981-8160 Fax: 717-312-3094 |
Christopher Moyer, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Corporate Center Dr Ste 100, Camp Hill, PA 17011 Phone: 717-763-7037 Fax: 717-763-8960 |
John A Belis, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 423 N 21st St, Ste 300, Camp Hill, PA 17011 Phone: 717-763-1174 Fax: 717-763-8960 |
News Archive
Cancer patients fear the possibility that one day their cells might start rendering many different chemotherapy regimens ineffective. This phenomenon, called multidrug resistance, leads to tumors that defy treatment.
A new review by David A. Walsh and Joanne Stocks in the September 2017 issue of SLAS Discovery (formerly the Journal of Biomolecular Screening) explores evolving treatments and future therapies for osteoarthritis (OA) pain.
The study results could significantly change the way the illness is managed in developing countries, saving a significant number of lives every year and taking pressure off health systems.
HealthSpring, Inc. today announced that it has entered into a definitive agreement to acquire all of the outstanding capital stock of Bravo Health, Inc., an operator of Medicare Advantage coordinated care plans in Pennsylvania, the Mid-Atlantic region, and Texas, and Medicare Part D stand-alone prescription drug plans in 43 states.
› Verified 1 days ago